Senestech (SNES) Stock Price

Senestech Price

NASDAQ·CLOSED
0.76
​
Market closed

Over the last 11 years Senestech grew revenue by 24.5% annually, reaching 2.22 M USD. For Senestech, the net margin of -287.4% is up versus -1,435.4% a few years ago.

Senestech stock price

Access this data via the Eulerpool API

Senestech business model & stock analysis

SenesTech, Inc. engages in the development and commercialization of a proprietary technology for the management of animal pest populations, primarily rat populations through fertility control. The company is headquartered in Flagstaff, Arizona and currently employs 34 full-time employees. The company went IPO on 2016-12-08. Its product ContraPest, is in the pest control industry in attacking the reproductive systems of both male and female rats. ContraPest targets the reproductive capabilities of rodents by inducing the gradual loss of eggs in female rodents and disruption of sperm in male rodents, resulting in contraception that can progress to sterility in both females and males. Its pipeline includes feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. Its Feral animal fertility control has its application in the population management segment and targets feral dogs and hogs. Its Non-Surgical Spay and Neutering have its application in companion animal health, and targets companion dogs and cats. The firm's Boar taint has its application in food production and safety and targets boars.

Frequently asked questions about Senestech

7 analysts currently rate the Senestech stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Senestech to generate revenue of 2.93 M USD and earnings per share of -1.38 USD.

Converted at the current exchange rate, the Senestech share trades at 0.68 EUR (0.76 USD).

The Senestech share (SNES) is listed on 2 stock exchanges, including: NASDAQ (SNES), Frankfurt (SE81.F).

The expected revenue of Senestech is 2.93 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Senestech is -7.23 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Senestech is currently -0.55. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Senestech stock.

The price-to-sales ratio (P/S) of Senestech is currently 1.36. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Senestech stock.

The Eulerpool Quality Score for Senestech is 4/10.

The ISIN of Senestech is US81720R6045. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Senestech is A2PW5C. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Senestech is SNES. The ticker symbol is used to trade Senestech shares on the stock exchange.

Fair ValueTerminal
0.64 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
96,565.22 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Dec 8, 2016
ISIN
US81720R6045
Cusip
81720R208
Sedol
BK5C7Y3
Market capitalization
3.99 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-0.55
P/Ee 2027
-0.69
P/Ee 2028
-2.01
P/Ee 2029
3.48
P/Ee 2030
1.66
P/S
P/Se
1.36
EV/EBIT
0.14
P/B Ratio
0.42
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-52.13 %
Last updated Oct 9, 2026, 6:22 AM

Senestech Ticker

FRANKFURT · SE81.FNASDAQ · SNES

All fundamentals and in-depth analysis of Senestech

Our stock analysis for Senestech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Senestech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.